Pharmaniaga Bhd said early data from studies shows that the Sinovac vaccine booster shots are 94% effective against the Omicron variant.
The studies by Sinovac Biotech Co Ltd involved two strains of the new variant from Hong Kong, it said in a statement on Saturday (December 18th).
Photo via DW
According to The Edge Market, lab results showed that when tested against one of the Omicron strains, 35% of the 20 serum samples (7/20) from recipients of two CoronaVac doses tested positive for neutralising antibody, and 94% of the 48 samples (45/48) from recipients of three doses tested positive for the neutralising antibody.
Pharmaniaga added that Sinovac is conducting further studies involving sera with different antibody levels and at a wider variety of post-immunisation points of time in order to achieve a comprehensive evaluation of Omicron’s impact on the vaccine.
They added that these scientific studies also are in line with the statement made by Health Minister Khairy Jamaluddin on Friday asking all adult Sinovac recipients and those above 60 years old, regardless of their types of vaccines, to take the booster shots by end-February 2022.
Please get the booster shots if you’re eligible.
Take care of yourself and the people around you… We’re all in this together!
By: Aishah Akashah Ahadiat
